INTRODUCTION
============

Proteins are inherently dynamic structures. Regulating the transition between conformational states is critical for proper function and, on a larger scale, maintaining control of a multitude of physiological processes. Ion channels are one class of protein that exemplifies this connection between structure and function, since switching between open and closed states controls a whole host of physiological responses. In this study, we probe the nature of these transitions and how they are controlled by external factors in the Ca^2+^-activated potassium channel (KCa3.1) ([@bib17]; [@bib18]). KCa3.1 is composed of four subunits, each having six transmembrane domains (S1--S6) with a pore domain located between S5 and S6. Channel activation is mediated through a Ca^2+^-dependent gating mechanism, which is dependent on the coassembly of channel α-subunit with calmodulin (CaM) ([@bib37]). CaM, a Ca^2+^-binding protein, is constitutively bound to the channel's CaM-binding domain (CaMBD) located in the C terminus, just distal to S6. Upon binding of Ca^2+^ to CaM, the CaM/CaMBD undergoes a conformational change, which is coupled to the pore, enabling the channel to transition from a nonconducting to a conducting configuration ([@bib19]; [@bib23]). This association allows CaM to behave as an intracellular Ca^2+^ sensor, coupling changes in intracellular Ca^2+^ concentration to the regulation of channel activity. The unique association with CaM allows this channel to regulate the molecular signaling mechanisms underlying the control of vascular tone ([@bib8]). In vascular endothelium, cell stimulation initiates an increase in intracellular Ca^2+^ (Ca^2+^~i~). Increasing Ca^2+^~i~ activates KCa3.1, resulting in endothelial cell hyperpolarization, a requirement for the initiation of the endothelial derived hyperpolarizing factor (EDHF) response ([@bib2]). The activation of this EDHF pathway ultimately results in the hyperpolarization of adjacent vascular smooth muscle cells, which enables subsequent arteriolar dilation and decrease in vascular tone ([@bib6]; [@bib7]).

Activation of the EDHF pathway and subsequent regulation of vascular tone is dependent on tight regulation of KCa3.1 channel activity. Although little is understood regarding the coupling mechanism in these channels, the C-terminal portion of S6 is thought to transform the activation energy from the CaM/CaMBD into a mechanical force to alter the conformational state of the pore ([@bib30], [@bib31]; [@bib33]; [@bib20]; [@bib9]). The first investigation examining the pore architecture of KCa3.1 used the substituted cysteine accessibility method to identify a region within S6 that is expected to contribute to the lumen (V275-V282) and a second region expected to participate in the activation mechanism (A283-A286) ([@bib33]). Additionally, it has been suggested that in the closed conformation, the cytoplasmic ends of S6 do not function as a barrier to the movement of K^+^ ions ([@bib20]) as it does in KcsA ([@bib5]). Rather, the activation gate is suggested to be located at or near the selectivity filter, with the C-terminal portion of S6 (V282-A286) participating in the activation mechanism ([@bib33]; [@bib20]; [@bib9]). However, in contrast to the previous investigations, which determined the role of cysteines engineered along the luminal face of S6, we observe that the nonluminal face of S6 also participates in the activation mechanism. Cys^276^ and Leu^281^ are predicted to have a nonluminal orientation, and our results suggest that perturbations at these positions, using either parachloromercuribenze sulfonate (PCMBS) (Cys^276^) or tryptophan substitution (Trp^281^), shifts the gating equilibrium toward the open conformation. Activation and deactivation kinetics, as measured by Ca^2+^ jump experiments, are markedly slowed, suggesting that perturbing these positions disrupts a transition that is allosterically coupled to the activation gate. Therefore, our results indicate the transition of KCa3.1 to the closed conformation is dependent on the interaction surface formed by the nonluminal face of S6, specifically the C-terminal portion of the helix. Results from our kinetic analysis indicate that PCMBS and L281W disrupt channel behavior through a common mechanism by manipulating the transition from the open state back to the third and final closed state. Our results, together with previous investigations, lead us conclude that the luminal and nonluminal faces of the C-terminal portion of S6 actively function to couple the conformational changes in the CaM/CaMBD to the pore, thus permitting the channel to transition from a nonconducting to a conducting conformation.

MATERIALS AND METHODS
=====================

Molecular biology
-----------------

KCa3.1 (hIK1) cDNA was provided by J.P. Adelman (Oregon Health Sciences University, Portland, OR). The cDNA was subcloned into pcDNA3.1(+) (Invitrogen) using the EcoRI and XhoI restriction sites. All mutations were generated using the Agilent Technologies QuikChange site-directed mutagenesis strategy. The fidelity of all constructs used in this study were confirmed by sequencing (ABI PRISM 377 automated sequencer, University of Pittsburgh) and subsequent sequence alignment (National Center for Biotechnology Information BLAST) using GenBank/EMBL/DDBJ accession no. AF022150.

Cell culture
------------

Human embryonic kidney (HEK293) cells were obtained from the American Type Culture Collection and cultured in Dulbecco's modified Eagle's medium (Invitrogen) supplemented with 10% fetal bovine serum and 1% penicillin-streptomycin in a humidified 5% CO~2~/95% O~2~ incubator at 37°C. Cells were transfected using LipofectAMINE 2000 (Invitrogen) according to the manufacturer's instructions. Stable cell lines were generated for all constructs by subjecting cells to antibiotic selection (1 mg/ml G418). Note that clonal cell lines were not subsequently selected from this stable population to avoid clonal variation.

Electrophysiology
-----------------

The effects of PCMBS on KCa3.1 were assessed with inside-out patch-clamp experiments as a functional assay. Currents were recorded using an Axopatch 200B amplifer (Axon Instruments, Inc.). During patch-clamp experiments, the bath solution contained 145 mM potassium-gluconate, 5 mM KCl, 1.3 mM MgCl~2~, 10 mM HEPES, 1 mM EGTA, and 300 µM ATP (pH adjusted to 7.2 with KOH). Sufficient CaCl~2~ was added to obtain the desired free Ca^2+^ concentration (program provided by D. Dawson, Oregon Health Sciences University) and applied to the intracellular surface of the patch through a rapid solution exchanger (RSC-160; Biological). To obtain a Ca^2+^-free bath solution, EGTA (1 mM) was added without CaCl~2~ (estimated free Ca^2+^ \<10 nM). Electrodes were fabricated from thin-walled borosilicate glass (World Precision Instruments), pulled on a vertical puller (Narishige), fire polished, and had a resistance of 1--5 MΩ. The pipette solution was 140 mM potassium-gluconate, 5 mM KCl, 1 mM MgCl~2~, 10 mM HEPES, and 1 mM CaCl~2~ (pH adjusted to 7.2 with KOH). All experiments were performed at room temperature. All patches were held at a holding potential of −100 mV. The voltage is referenced to the extracellular compartment, as is the standard method for membrane potentials. Inward currents are defined as the movement of positive charge from the extracellular compartment to the intracellular compartment and are presented as downward deflections from the baseline in all recordings. Ionic currents were low-pass filtered at 2 kHz by using an AxoPatch 200B amplifier and digitized at 5 kHz using a Digidata 1322A interfaced with a PC computer running pCLAMP 9.2 software (all instruments including software; Axon Instruments, Inc.). Currents were analyzed using Clampfit 9.2 (Axon Instruments, Inc.) and Biopatch software (version 3.3, Bio-logic).

Variance analysis
-----------------

Macroscopic membrane patches were excised into 10 µM Ca^2+^, after which a complete Ca^2+^ concentration response experiment was performed (see [Fig. 2 A](#fig2){ref-type="fig"} for specific details). At the end of the Ca^2+^ concentration response experiment, PCMBS (500 µM) was added to the 10 µM Ca^2+^ concentration, and the experiment continued until the current reached a second steady-state PCMBS-mediated maximum current level. The total current record, to be used for variance analysis, was divided into 250 episodes, and mean current 〈I〉 and variance (σ^2^) were calculated for each episode using Channelab Software (Synaptosoft Inc.). The increase in channel open probability (P~o~), mediated through PCMBS, was estimated by determining the difference between the P~o(max)~ value in the presence and absence of PCMBS. Furthermore, the number of channels (N) in the patch and single channel amplitude (i) are obtained by fitting the σ^2^ against 〈I〉 distribution to [Eq. 1](#fd1){ref-type="disp-formula"}:$$\sigma^{2} = iI - \frac{I^{2}}{N}.$$The P~o(max)~ can then be calculated using [Eq. 2](#fd2){ref-type="disp-formula"}:$$P_{o(max)} = \frac{I_{\max}}{iN},$$where I~max~ is the maximum current observed and i and N are the mean values for single channel amplitude and number of channels calculated from [Eq. 1](#fd1){ref-type="disp-formula"}. The product of i and N would give the theoretical current at P~o~ = 1, hence, channel P~o~ can be calculated at any given current as a proportion of P~o(max)~ ([@bib32]).

Ca^2+^ jump experiments
-----------------------

Macroscopic membrane patches expressing KCa3.1 were excised from HEK293 cells and intracellular solution was quickly switched using a rapid solution exchanger (RSC-160; Biological). To estimate the kinetics of activation and deactivation, the protocol requires that the internal solution be alternated between a Ca^2+^-free solution for 3 s and a series of Ca^2+^-containing solutions (concentrations reported in the results section) for 1.5 s with a 5-ms interval between switches. Activation and deactivation currents were recorded, superimposed, and averaged using Clampfit 9.2 (Axon Instruments, Inc.) software. Time constants describing channel activation and deactivation kinetics were determined by fitting the activation and deactivation current records with a standard single exponential function. The deactivation kinetics were well described using a single exponential. However, the activation kinetics were sigmodal in shape, due to the delay in channel activation, and not well described with a single exponential function. This delayed response in channel activation can be explained through two factors. The first factor is based upon the volume of solution that must be exchanged between the surface of the patch and the tip of the patch pipette. The larger the volume, the longer it takes for a complete solution exchange, thus increasing the duration of the delay in channel activation. Because this factor is dictated by the size and positioning of the membrane relative to the tip of the pipette, this will vary between patches and for these purposes is considered rate limiting. The second factor contributing to the delay in channel activation is the multiple (two or more) transitions the channel must pass through before entering the open state ([@bib40]). Assuming the number of conformational transitions along the activation pathway is equal between channels, this factor can be considered constant across all experiments. Therefore, these two factors summed together manifest as the delay in channel activation. However, we failed to notice a correlation between the duration of delay in channel activation verses Ca^2+^ concentration and thus no further effort was made to analyze this component in the context of channel activation kinetics. Therefore, when fitting the current record to estimate activation kinetics, the delay in channel activation was disregarded, which left the remaining portion of the current recording that is well described by a single exponential function ([@bib34]).

Modeling
--------

The six-state kinetic model illustrated in [Fig. 10 A](#fig10){ref-type="fig"} was solved numerically to quantify how PCMBS perturbs the gating of KCa3.1 and to understand the overall contribution of S6 to the Ca^2+^-dependent gating mechanism. Forward and reverse rate constants are labeled according to the channel state such that k~ij~ is the rate of going from state i to state j. Thus, the model has 10 rate constants k~12~, k~23~, k~34~, k~35~, and k~46~ are the forward rate constants, and k~21~, k~32~, k~43~, k~53~, and k~64~ are the reverse rate constants. The Ca^2+^-dependent transitions are represented by the forward rate constants k~12~, k~23~, and k~34~, and all other transitions are assumed to be Ca^2+^ independent. We explored two versions of the model with regard to the Ca^2+^ dependence of these rate constants. First, we constructed a model in which the rate of Ca^2+^ binding varied linearly with Ca^2+^ concentration, k = A · \[Ca\], where A is a constant as proposed for KCa2.3 ([@bib14]). Second, we constructed a model in which the rate of Ca^2+^ binding varied nonlinearly with Ca^2+^ concentration, k = A · \[Ca\]/(B + \[Ca\]), where A and B are constants. The second rate takes the form of a Michaelis-Menten equation in which the rate of binding saturates at high Ca^2+^~i~ as further discussed in the results section. We used an 11th independent variable, N, to scale the single channel current resulting from the model to match macroscopic experimental currents. Thus, N represents the number of active channels in the patch. For a particular set of rate constants, we solved the system of equations corresponding to [Fig. 10 A](#fig10){ref-type="fig"} using a stiff solver routine in Matlab (7.6). We then calculated the root mean square difference between the simulated channel current and the experimentally recorded trace. Next, we used a Nelder-Mead search algorithm to search through parameter space in an attempt to minimize the root mean square difference ([@bib28]). A typical search involved solving the model 50,000 times for each Ca^2+^ concentration. Furthermore, the search algorithm was rerun on each dataset several times in an attempt to thoroughly explore parameter space for the best fit. This entire procedure was performed for datasets recorded in the absence or presence of PCMBS to identify the transitions modulated by this compound.

The six-state scheme was also used to predict the apparent Ca^2+^ affinity and shift in apparent affinity observed with PCMBS. Channel P~o~ was calculated from the model over the range of experimentally measured Ca^2+^ concentrations, and the corresponding EC~50~ was extracted from the resulting curve. We determined channel P~o~ at each Ca^2+^~i~ concentration by running the model to steady state and dividing the probability of being in the open state (states 5 and 6) by the total probability (sum of states 1 through 6).

Sensitivity analysis
--------------------

To determine which parameters were most critical for fitting the data, we varied each rate constant by ±10%, reran the model, and calculated the percent change in the error. This analysis was only performed on the final set of parameter values that produced the best fit for any given condition.

Structural modeling
-------------------

We constructed a homology model of the pore domain of KCa3.1 with Modeller 9v7 ([@bib29]) using Kv1.2 (PBD ID 2A79) and KcsA (PDB ID 1BL8) as a template structure.

Hill equation
-------------

Ca^2+^ concentration response experiments were plotted as normalized current (I/Imax) against the corresponding Ca^2+^ concentration p\[Ca^2+^\],M and were fit with the following version of the Hill equation: I = I~min~ + (I~max~ − I~min~)/(1 + 10^((LogEC50-X)\*HillSlope)^). Fitting was performed using Prizm (GraphPad Software, Inc.).

Chemicals
---------

All chemicals were obtained from Sigma-Aldrich, unless otherwise stated. Adenosine-5′-triphosphate obtained from Roche and PCMBS from Toronto Research Chemicals Inc. were freshly made on the day of the experiment and added directly to the bath solution before the experiment.

Online supplemental material
----------------------------

The results from the sensitivity analysis are available online (Table S1) as an individual table for each dataset. Online supplemental material is available at <http://www.jgp.org/cgi/content/full/jgp.201010430/DC1>.

RESULTS
=======

PCMBS can be used as a probe to modulate KCa3.1 gating
------------------------------------------------------

It was previously demonstrated that \[2-(trimethylammonium)\]methanethiosulfonate bromide only transiently inhibits WT-KCa3.1 steady-state behavior ([@bib33]). Therefore, we wanted to determine whether PCMBS could alter steady-state current in excised membrane patches expressing KCa3.1. As shown in [Fig. 1 (A--C)](#fig1){ref-type="fig"}, addition of PCMBS (500 µM) to the membrane patch increased channel activity at 0.3 µM (A), 0.6 µM (B), and 10 µM (defined as saturating) Ca^2+^~i~ concentrations. Furthermore, the effect of PCMBS could not be reversed upon washout, suggesting a covalent interaction between channel cysteine(s) and the sulfhydral-reactive compound. To address whether PCMBS could activate KCa3.1 in the absence of Ca^2+^~i~, experiments were performed in which PCMBS (500 µM) was added after the addition of a Ca^2+^-free bath solution. As shown in [Fig. 1 D](#fig1){ref-type="fig"}, PCMBS is unable to activate KCa3.1 in the absence of Ca^2+^~i~, demonstrating that the compound potentiates channel current rather than directly activating the channel. Only after the addition of Ca^2+^~i~ can PCMBS increase steady-state current, suggesting the closed conformation prevents PCMBS from accessing the endogenous cysteine residue(s). Our results illustrate that PCMBS can covalently bind to endogenous cysteine residue(s), and these residue(s) must reside within a gating-sensitive region of the channel.

![PCMBS increases KCa3.1 steady-state current. Macroscopic current records from KCa3.1 channels heterologously expressed in HEK cells to determine sensitivity to PCMBS. PCMBS (500 µM) was added to inside-out patches excised in 0.3 (A), 0.6 (B), and 10 µM (C) Ca^2+^~i~ after the establishment of steady-state current level. PCMBS washout lasted at least 1 min to ensure channel activation was due to covalent binding, rather than an indirect interaction between channel and compound. (D) KCa3.1 current record demonstrating that PCMBS cannot activate the channel in the absence of Ca^2+^~i~. PCMBS can only increase current when the channel is in the open state. The patch was initially excised in 10 µM Ca^2+^~i~, followed by the addition of a Ca^2+^~i~-free solution, and then a Ca^2+^~i~-free solution+PCMBS (500 µM) was added to the bath solution. PCMBS+Ca^2+^~i~-free solution was washed out with 10 µM Ca^2+^~i~ to reactivate the channel. After reaching a steady-state current level, PCMBS (500 µM) was reapplied to the patch, resulting in channel activation.](JGP_201010430_LW_Fig1){#fig1}

Characterization of potentiation by PCMBS
-----------------------------------------

To gain insight into the mechanism by which PCMBS activates KCa3.1, we determined whether PCMBS increases steady-state current through an increase in N, P~o~, or i using variance analysis, as described in the Materials and methods section. [Fig. 2 A](#fig2){ref-type="fig"} depicts a representative current record in which a series of Ca^2+^~i~ concentrations were applied to the intracellular face of an inside-out patch expressing KCa3.1 channels, and after establishment of steady-state current in 10 µM Ca^2+^~i~, PCMBS (500 µM) was added to the bath. This current record was used to calculate σ^2^ both in the absence (portion of the record excluding PCMBS) and presence (entire record) of PCMBS. Plotting σ^2^ against 〈I〉 and fitting this relationship with [Eq. 1](#fd1){ref-type="disp-formula"} gave estimates of N, P~o~, and i ([Fig. 2, B and C](#fig2){ref-type="fig"}). Analysis of these data indicate that potentiation results from a 50% increase in P~o(max)~ (from 0.61 to 0.91 in PCMBS) rather than changes to N (1071 versus 1078 in PCMBS) or i (3.5 pA versus 3.4 pA in PCMBS). Analysis of multiple experiments (*n* = 12) revealed that PCMBS increases P~o(max)~ from 0.65 ± 0.03 to 0.93 ± 0.02 without an increase in N or i (3.3 ± 0.03 pA versus 3.3 ± 0.03 pA in PCMBS). Given the variability of N across patches, its average was not calculated. These data suggest that PCMBS acts through a Ca^2+^-independent pathway to increase steady-state current through an increase in P~o(max)~.

![PCMBS increases steady-state P~o(max)~. Variance analysis of KCa3.1 channel current was used to estimate P~o(max)~, N, and i in the absence and presence of PCMBS. (A) Representative Ca^2+^ concentration response experiment recorded from inside-out macropatches expressing KCa3.1 channels. Patches were initially excised in 10 µM Ca^2+^~i~, followed by a series of Ca^2+^~i~ concentrations (0, 0.1, 0.15, 0.2, 0.25, 0.3, 0.6, 1.0, and 10 µM) applied for 10-s intervals using a fast solution exchanger. After establishing steady-state current in 10 µM Ca^2+^~i~, PCMBS (500 µM) was added to the bath solution until reaching a second, steady-state, current level. (B) Variance analysis to determine P~o(max)~, N, and i in the absence of PCMBS. Plot of variance (σ^2^), which was calculated from the portion of the record excluding the time when PCMBS was added, against mean current 〈I〉 as fit with [Eq. 1](#fd1){ref-type="disp-formula"} (solid line), and P~o(max)~ was calculated using [Eq. 2](#fd2){ref-type="disp-formula"}: P~o(max)~ = 0.61, *n* = 1,071, and i = 3.5 pA. (C) Variance analysis to determine P~o(max)~, N, and i in the presence of PCMBS. Plot of σ^2^, which was calculated from the entire record against 〈I〉 was fit with [Eq. 1](#fd1){ref-type="disp-formula"} (solid line), and P~o(max)~ was calculated using [Eq. 2](#fd2){ref-type="disp-formula"}: P~o(max)~ = 0.91, *n* = 1,078, and i = 3.4 pA.](JGP_201010430_LW_Fig2){#fig2}

Importantly, the steady-state current increase observed in saturating Ca^2+^ would mask any increase in channel activation occurring through a Ca^2+^-dependent pathway. Therefore, to determine whether PCMBS also affects the Ca^2+^-dependent pathway, we measured the apparent Ca^2+^ affinity in the absence and presence of PCMBS as shown in [Fig. 3 A](#fig3){ref-type="fig"}. This figure illustrates that PCMBS induced a significant current potentiation between 0.1 and 0.3 µM Ca^2+^~i~ compared with the equivalent current increase in the absence of the compound. These data were fit to a version of the Hill equation, [Fig. 3 B](#fig3){ref-type="fig"}, demonstrating a PCMBS-dependent shift in the EC~50~ from 508 ± 13 nM (*n* = 57) to 235 ± 17 nM (*n* = 6) without altering the Hill coefficient (2.0 ± 0.2 and 2.5 ± 0.2). These results indicate that PCMBS increases channel activation through both Ca^2+^-independent and -dependent pathways, reflected by an increase in P~o(max)~ and a shift in apparent Ca^2+^ affinity, respectively.

![PCMBS shifts apparent Ca^2+^ affinity. Complete Ca^2+^ concentration response experiments were performed to estimate EC~50~ and the Hill coefficient (h) in the absence and presence of PCMBS. (A) Representative macroscopic current record from an inside-out patch--expressing KCa3.1 channels. The patch was excised in 10 µM Ca^2+^~i~ followed by a series of Ca^2+^~i~ concentrations beginning with 0, 0.1, 0.3, 0.6, 1.0, 3.0, and 10 µM Ca^2+^~i~ , all applied in 10-s intervals using a rapid solution exchanger. After the current reached a steady-state level, PCMBS (500 µM) was added, and a second Ca^2+^~i~ concentration response experiment was performed using the above Ca^2+^~i~ concentrations in the presence of PCMBS. (B) Plot of normalized 〈I〉 current against the corresponding Ca^2+^~i~ for KCa3.1 (■) and KCa3.1+PCMBS (▾) fit with a variation of the Hill equation (see Materials and methods). This analysis gave estimates for KCa3.1 (solid line, *n* = 57), EC~50~ = 508 ± 13 nM and h = 2.0 ± 0.2, and KCa3.1+PCMBS (dashed line, *n* = 6), EC~50~ = 235 ± 17 nM and h = 2.5 ± 0.2. All experiments were done in pairs, but an alternate set of Ca^2+^~i~ concentrations (0.1, 0.15, 0.2, 0.25, 0.3, 0.6, 1.0, and 10 µM) were used when estimating EC~50~ and h for KCa3.1+PCMBS. Error bars represent SEM. The error bars for KCa3.1 are smaller than the symbols (■).](JGP_201010430_LW_Fig3){#fig3}

Our results suggest that PCMBS shifts the gating equilibrium toward the open state, which we expect to be manifested as a change in the activation or deactivation kinetics of the channel. To determine which of these kinetic steps is being modified, we measured the kinetics of channel activation and deactivation in the absence and presence of PCMBS. The patch was excised in 10 µM Ca^2+^~i~, after which Ca^2+^~i~ was rapidly switched between a Ca^2+^-free solution and a Ca^2+^~i~ solution, as depicted in the inset of [Fig. 4](#fig4){ref-type="fig"}. After 5--10 complete cycles (one cycle consists of taking measurements using 0.5 \[A\], 0.7 \[B\], 1.0 \[C\], and 10 \[D\] μM Ca^2+^~i~), PCMBS was added to the bath solution and the protocol was repeated. Because PCMBS increases current at all Ca^2+^ concentrations, current recordings were normalized to the maximum current level to compare channel kinetics in the absence and presence of PCMBS. Additionally, current records for each Ca^2+^~i~ concentration were superimposed and averaged to produce the representative current records shown in [Fig. 4 (A--D)](#fig4){ref-type="fig"}. Time constants (τ) for channel activation and deactivation were determined from fits of the data to a single exponential and reported in [Fig. 4 (E and F)](#fig4){ref-type="fig"}, see also [Table I](#tbl1){ref-type="table"}. As shown, the data demonstrate that the activation kinetics are Ca^2+^ dependent, becoming faster with increased Ca^2+^~i~ concentration, whereas the deactivation kinetics are Ca^2+^ independent, being insensitive to changes in Ca^2+^~i~ concentration. The addition of PCMBS, [Fig. 4 (A--D)](#fig4){ref-type="fig"} results in a sixfold increase in the time constant for deactivation ([Fig. 4 F](#fig4){ref-type="fig"}) with only moderate effects on the time course for activation ([Fig. 4 E](#fig4){ref-type="fig"}, see also [Table I](#tbl1){ref-type="table"}).

###### 

Exponential fits comparing the activation and deactivation kinetics of KCa3.1

  Channel           \[Ca^2+^\]~i~   On         Off        *n*   PCMBS                 
  ----------------- --------------- ---------- ---------- ----- ---------- ---------- ----
                    *μM*            *ms*       *ms*             *ms*       *ms*       
  KCa3.1 (paired)   0.5             224 ± 22   61 ± 5     13    337 ± 29   402 ± 31   13
                    0.7             185 ± 11   60 ± 5     13    250 ± 14   414 ± 30   13
                    1.0             147 ± 9    65 ± 4     13    224 ± 12   428 ± 30   13
                    10              123 ± 11   59 ± 4     13    206 ± 13   411 ± 34   13
  KCa3.1 C276A      0.5             211 ± 20   48 ± 4     7     191 ± 12   60 ± 8     7
                    0.7             186 ± 15   46 ± 4     7     154 ± 13   57 ± 6     7
                    1.0             142 ± 15   56 ± 3     7     134 ± 12   61 ± 6     7
                    10              120 ± 11   43 ± 3     7     103 ± 6    59 ± 6     7
  KCa3.1 C277A      0.5             244 ± 10   54 ± 6     6     318 ± 20   377 ± 45   5
                    0.7             186 ± 9    59 ± 6     6     262 ± 18   336 ± 46   5
                    1.0             152 ± 8    59 ± 5     6     223 ± 19   365 ± 44   5
                    10              129 ± 12   59 ± 7     6     194 ± 14   332 ± 39   5
  KCa3.1            0.5             209 ± 9    57 ± 2     51                          
                    0.7             170 ± 5    57 ± 2     51                          
                    1.0             141 ± 5    59 ± 2     51                          
                    10              114 ± 5    56 ± 2     51                          
  KCa3.1 L281W      0.5             149 ± 12   186 ± 11   23    175 ± 20   267 ± 20   8
                    0.7             130 ± 9    202 ± 11   23    142 ± 17   278 ± 24   8
                    1.0             119 ± 10   198 ± 9    23    119 ± 13   293 ± 27   8
                    10              92 ± 7     197 ± 9    23    100 ± 10   288 ± 27   8
  KCa3.1 V282W      0.5             161 ± 11   59 ± 3     13                          
                    0.7             131 ± 8    59 ± 2     13                          
                    1.0             113 ± 8    59 ± 3     13                          
                    10              84 ± 5     58 ± 3     13                          

Time constants (τ) from single exponential fits to channel activation or deactivation records from the four \[Ca^2+^\]~i~ concentrations examined.

![PCMBS modulates channel kinetics. Activation and deactivation kinetics were estimated with Ca^2+^ jump experiments in the absence and presence of PCMBS. A rapid solution exchanger was used to quickly alternate between a Ca^2+^~i~-free solution and one of four Ca^2+^~i~ solutions: (A) 0.5, (B) 0.7, (C) 1.0, and (D) 10 µM Ca^2+^~i~ according to the protocol illustrating one complete Ca^2+^ cycle shown in the inset of this figure. 5--10 complete Ca^2+^ cycles were recorded from a single patch in the absence and presence of PCMBS (500 µM). Activation and deactivation sweeps in the absence of PCMBS (black trace) were collected and averaged according to their respective Ca^2+^ concentration and superimposed against the corresponding PCMBS sweep (red trace). Current traces were normalized to the max current level, facilitating comparison of time courses between KCa3.1 and KCa3.1+PCMBS. Activation (E) and deactivation (F) rates were estimated by fitting activation and deactivation records with an exponential function and reported as a time constant (τ-on and τ-off) in the absence (▴) and presence (▵) of PCMBS, see also [Table I](#tbl1){ref-type="table"}.](JGP_201010430_RGB_Fig4){#fig4}

Cysteine 276 confers PCMBS sensitivity to KCa3.1 potentiation
-------------------------------------------------------------

Potentiation by PCMBS is the result of cysteine modification, and KCa3.1 contains nine endogenous cysteines residues. [Fig. 5 A](#fig5){ref-type="fig"} illustrates a model of the pore region for the open state of KCa3.1 obtained by homology modeling using the rKv1.2 channel structure ([@bib25]). This model shows that the four endogenous cysteine residues (267, 269, 276, and 277) are located along S6, making these residues likely candidates for conferring PCMBS sensitivity. To isolate the residue(s) responsible for the PCMBS-mediated potentiation, each cysteine was mutated to an alanine and the effect of PCMBS determined. However, C267A and C269A failed to produce macroscopic currents, preventing their assessment in PCMBS-mediated channel potentiation. Therefore, we tested whether PCMBS (500 µM) could potentiate current in the C276A and C277A constructs. A representative Ca^2+^ concentration response experiment for C277A is shown in [Fig. 6 A](#fig6){ref-type="fig"}. PCMBS increases steady-state current in 10 µM Ca^2+^~i~ (left), in addition to causing a left shift in apparent Ca^2+^ affinity (right). Furthermore, washout of PCMBS does not reverse the increase in current (unpublished data), demonstrating that PCMBS still covalently binds to the channel. We confirm through variance analysis ([Fig. 6, B and C](#fig6){ref-type="fig"}) that the steady-state current increase in saturating Ca^2+^~i~ is the result of an increase in P~o(max)~ (see figure legend for details). Additionally, the C277A mutation did not alter the apparent Ca^2+^ affinity or the P~o(max)~ relative to the WT channel, suggesting the increase in C277A activation is due to the binding of PCMBS and not to the mutation having an indirect effect on channel gating. In total, these results demonstrate the PCMBS-mediated channel activation does not require Cys^277^.

![Homology model of the pore region for the open state of KCa3.1 using the rKv1.2 structure. (A) Representation of the S5-P-helix-S6 region viewed as a profile illustrating the predicted orientation of Cys^267^, Cys^269^, Cys^277^ (all in gray), Cys^276^ (yellow), and Leu^281^ (red). Only two of the four subunits are shown for clarity. (B) Representation of the S5-P-helix-S6 region from the extracellular entrance showing the predicted nonluminal orientation of Cys^276^ (yellow) and Leu^281^ (red). The S5 and P-helix are colored green and the S6 helix is colored blue. All residues are illustrated in VDW format. (C) Sequence alignment used for the homology model of KCa3.1 in the open state (rKv1.2) and the closed state (KcsA model illustrated in [Fig. 15](#fig15){ref-type="fig"}). Bold font represents homologous amino acids used as a guide to align sequences.](JGP_201010430_RGB_Fig5){#fig5}

![PCMBS increases channel activation for KCa3.1 C277A. Ca^2+^ concentration response experiments and variance analysis were undertaken to determine whether PCMBS increases C277A channel activation in the same manner observed for the WT channel. (A, left) Representative macroscopic current record from an inside-out patch expressing KCa3.1 C277A channels. All experiments were performed using the Ca^2+^ concentraiton response protocol described in [Fig. 3](#fig3){ref-type="fig"}. (A, right) Plot of normalized 〈I〉 current against the corresponding \[Ca^2+^\]~i~ for KCa3.1 C277A (■) and KCa3.1 C277A+PCMBS (▾). All analysis was performed according to the protocol described in [Fig. 3](#fig3){ref-type="fig"} to give averages: KCa3.1 C277A (solid line, *n* = 15), EC~50~ = 566 ± 24 nM and h = 1.9 ± 0.1, and KCa3.1 C277A+PCMBS (dashed line, *n* = 7), EC~50~ = 220 ± 14 nM and h = 1.7 ± 0.2. Error bars represent SEM. (B) Variance analysis as described in [Fig. 2](#fig2){ref-type="fig"} to determine P~o(max)~, N, and i in the absence of PCMBS: P~o(max)~ = 0.51, *n* = 954, and i = 3.5 pA. (C) Variance analysis as described in [Fig. 2](#fig2){ref-type="fig"} to determine P~o(max)~, N, and i in the presence of PCMBS P~o(max)~ = 0.70, *n* = 849, and i = 3.5 pA. Analysis of multiple patches (*n* = 6) indicates that PCMBS increases P~o(max)~ from 0.55 ± 0.02 to 0.84 ± 0.03 without increasing N or i (3.8 ± 0.1 pA versus 3.9 ± 0.1 in PCMBS).](JGP_201010430_LW_Fig6){#fig6}

In contrast to the C277A mutation, C276A ([Fig. 7 A](#fig7){ref-type="fig"}) completely eliminated both the shift in apparent affinity ([Fig. 7 B](#fig7){ref-type="fig"}) and the increase of steady-state current in saturating Ca^2+^~i~ ([Fig. 7 C](#fig7){ref-type="fig"}, see figure legend for details). Additionally, the C276A mutation did not alter the apparent Ca^2+^ affinity or the P~o(max)~ relative to the WT channel, suggesting the absence of channel potentiation is due to removing Cys^276^, rather than the mutation having an indirect effect on channel gating. In total, these results indicate that channel potentiation is the result of PCMBS binding to Cys^276^.

![C276A prevents the PCMBS-mediated increase in channel activation. Ca^2+^ concentration response experiments and variance analysis were undertaken to determine whether PCMBS increases C276A channel activation in the same manner observed for the WT channel. (A) Representative macroscopic current record from an inside-out patch expressing KCa3.1 C276A channels. All experiments were performed using the Ca^2+^ concentraiton response protocol described in [Fig. 3](#fig3){ref-type="fig"}. (B) Plot of normalized 〈I〉 current against the corresponding Ca^2+^~i~ for KCa3.1 C276A (■) and KCa3.1 C276A+PCMBS (▾). All analyses were performed according to the protocol described in [Fig. 3](#fig3){ref-type="fig"} to give averages: KCa3.1 C276A (solid line, *n* = 18), EC~50~ = 460 ± 27 nM and h = 1.7 ± 0.04, and KCa3.1 C276A+PCMBS (dashed line, *n* = 9), EC~50~ = 485 ± 68 nM and h = 1.6 ± 0.04. Error bars represent SEM. (C) Variance analysis as described in [Fig. 2](#fig2){ref-type="fig"} to determine P~o(max)~, N, and i in the absence of PCMBS: P~o(max)~ = 0.67, *n* = 488, and i = 3.3 pA. PCMBS did not increase steady-state current in KCa3.1 C276A; therefore, to obtain an estimate of P~o(PCMBS)~, P~o~ had to be extrapolated using the equation where P~o~ = P~o(max)~(I/I~(max)~) and P~o(PCMBS)~ = 0.63. Analysis of multiple patches (*n* = 6) indicates that PCMBS did not increase P~o(max)~ (0.68 ± 0.05 in the absence of PCMBS and 0.59 ± 0.05 in PCMBS).](JGP_201010430_LW_Fig7){#fig7}

PCMBS modulated the kinetic as well as steady-state behavior of the WT channel. Therefore, we also determined whether Cys^276^ or Cys^277^ played a role in PCMBS-related changes to channel activation and deactivation. As depicted in [Fig. 8 (A--D)](#fig8){ref-type="fig"}, C277A activation and deactivation records were similar to the WT channel, both in the absence and presence of PCMBS. The average activation and deactivation time constants (τ) are plotted in [Fig. 8 (E and F](#fig8){ref-type="fig"}, respectively), as well as being reported in [Table I](#tbl1){ref-type="table"}. These results further demonstrate that Cys^277^ does not mediate the PCMBS-dependent potentiation of KCa3.1. However, as expected, Cys^276^ eliminated the PCMBS-dependent changes in the kinetic behavior of the channel ([Fig. 9, A--D](#fig9){ref-type="fig"}). The elimination of the PCMBS effect on kinetic behavior cannot be explained through an indirect effect of the Cys^276^ mutation, because the time course of activation and deactivation kinetics (in the absence of PCMBS) closely describe the values observed in the WT channel ([Table I](#tbl1){ref-type="table"}). Therefore, these results suggest that modification of the kinetic behavior is the result of PCMBS binding to Cys^276^.

![PCMBS modulates C277A channel kinetics in a manner similar to the WT channel. Activation and deactivation kinetics were estimated with Ca^2+^ jump experiments using Ca^2+^~i~ concentrations (A) 0.5, (B) 0.7, (C) 1.0, and (D) 10 µM in the absence (black trace) and presence (red trace) of PCMBS as described in [Fig. 4](#fig4){ref-type="fig"}. Activation (E) and deactivation (F) rates were estimated by fitting activation and deactivation records with an exponential function and reported as a time constant (τ-on and τ-off) in the absence (▴) and presence (▵) of PCMBS, see also [Table I](#tbl1){ref-type="table"}.](JGP_201010430_RGB_Fig8){#fig8}

![C276A prevents the PCMBS-mediated modulation on channel kinetics. Activation and deactivation kinetics were estimated with Ca^2+^ jump experiments using Ca^2+^~i~ concentrations 0.5, (A) 0.7, (B) 1.0, (C) and 10 µM (D) in the absence (black trace) and presence (red trace) of PCMBS as described in [Fig. 4](#fig4){ref-type="fig"}. Activation (E) and deactivation (F) rates were estimated by fitting activation and deactivation records with an exponential function and reported as a time constant (τ-on and τ-off) in the absence (•) and presence (○) of PCMBS, see also [Table I](#tbl1){ref-type="table"}.](JGP_201010430_RGB_Fig9){#fig9}

Gating of KCa3.1 can be described with a four-state model
---------------------------------------------------------

Our results demonstrate that PCMBS disrupts the steady-state and kinetic behavior of KCa3.1 by modifying Cys^276^. Addressing the mechanism behind PCMBS modification is necessary for understanding how the molecular interactions surrounding position 276 contribute to the gating mechanism. To this end, we developed a kinetic model, which would enable us to identify the transitions along the activation or deactivation pathway altered by PCMBS. A previous investigation established that the gating of KCa2.2 (SK2) can be described by a six-state gating scheme consisting of four closed states and two open states, with forward transitions between closed states being Ca^2+^ dependent ([@bib14]). Therefore, we determined if this model ([Fig. 10 A](#fig10){ref-type="fig"}) could be used to describe the activation and deactivation kinetics of the closely related channel, KCa3.1. Activation and deactivation current records were fit with the six-state model as described in the Materials and methods section. The solid lines in [Fig. 10 B](#fig10){ref-type="fig"} represent the fit to the activation and deactivation records assuming the Ca^2+^-dependent rate constants have a linear dependence on Ca^2+^ concentration, as proposed for KCa2.2 ([@bib14]). This model gave an accurate description of all datasets, except for the activation rate in saturating Ca^2+^~i~, where the model predicted activation rates that were faster than those observed experimentally. To obtain a more accurate description of the activation rate in saturating Ca^2+^~i~, we assumed that the Ca^2+^-dependent steps depended nonlinearly on the Ca^2+^ concentration. This modification allowed for the Ca^2+^-binding rate constants to saturate in high Ca^2+^~i~, giving a better description of the activation rates in 10 µM Ca^2+^~i~ ([Fig. 10 B](#fig10){ref-type="fig"}, dashed lines), and therefore, was used for all further analysis. Sensitivity analysis was used to evaluate the importance of each parameter to the goodness of the fits for both variations of the model ([Table S1](http://www.jgp.org/cgi/content/full/jgp.201010430/DC1)). This analysis showed that the final C-C and C-O transitions ([Fig. 10 A](#fig10){ref-type="fig"}, box outline) were not required to fit the four sets of activation and deactivation records ([Table II](#tbl2){ref-type="table"}). Rather, these data were well described with a simpler four-state model comprised of three closed states and one open state, and the best fit is achieved when the Ca^2+^-dependent rate constants saturate in high Ca^2+^.

###### 

Summary of the six-state model used to describe the kinetic behavior of KCa3.1 ± PCMBS

          KCa3.1             KCa3.1 + PCMBS                          Units
  ------- ------------------ ------------------ ---------- --------- --------------
  12      27 ± 3             10                 27         20        μM^−1^ s^−1^
  21      34 ± 8             76                 **34**     **34**    s^−1^
  23      5425 ± 2725        2911               **5425**   2820      μM^−1^ s^−1^
  32      190 ± 40           2978               **190**    **190**   s^−1^
  34      \-                 \-                 \-         \-        \-
  43      \-                 \-                 \-         \-        \-
  35      34 ± 7             291                **34**     **34**    s^−1^
  53      20 ± 5             3                  3          3         s^−1^
  46      \-                 \-                 \-         \-        \-
  64      \-                 \-                 \-         \-        \-
  error   38                 45                 42         43        
          **KCa3.1 L281W**   **KCa3.1 L281W**                        
          **A *n* = 1**      **B *n* = 1**                           
  12      11                 **27**                                  μM^−1^ s^−1^
  21      76                 **34**                                  s^−1^
  23      12380              **5425**                                μM^−1^ s^−1^
  32      192                **190**                                 s^−1^
  34      \-                 \-                                      \-
  43      \-                 \-                                      \-
  35      53                 **34**                                  s^−1^
  53      5                  **4**                                   s^−1^
  46      \-                 \-                                      \-
  64      \-                 \-                                      \-
  error   8                  13                                      

Rate constants derived from fitting the model to KCa3.1 activation and deactivation records. A, rates constants derived using the model with all free parameters: KCa3.1, KCa3.1+PCMBS, and KCa3.1 L281W; B, rates constants derived using the k~53~ model: KCa3.1+PCMBS and KCa3.1 L281W; C, rates constants derived using the k~12~ k~23~ and k~53~ model: KCa3.1+PCMBS. Bold, fixed to k~KCa3.1(-PCMBS)~.

![A four-state model can be used to fit the activation and deactivation kinetics for KCa3.1. (A) Gating scheme used to describe the activation and deactivation kinetics of KCa3.1. The six-state model is comprised of four closed states and two open states, with forward transitions between closed states being Ca^2+^ dependent and all other transitions being Ca^2+^ independent. The box outline represents the states that are not necessary to fit the activation and deactivation kinetics as determined through sensitivity analysis ([Table S1](http://www.jgp.org/cgi/content/full/jgp.201010430/DC1)). (B) Representative activation and deactivation records fit with two variations of the model shown in A. Activation and deactivation currents were recorded and fit according to the protocol described in the Materials and methods sections. The colors refer to the different Ca^2+^ concentrations, with red representing 0.5, blue 0.7, green 1.0, and black 10 µM Ca^2+^. The solid line represents the fit assuming Ca^2+^-dependent rate constants have a linear dependence on Ca^2+^ concentration, k = A · \[Ca\]. The dashed line represents the fit assuming Ca^2+^-dependent rate constants have a nonlinear dependence on Ca^2+^ concentration, k = A · \[Ca\]/(B + \[Ca\]). Rate constants derived from the fit are summarized in [Table II](#tbl2){ref-type="table"}. (C) The model can be used to predict the shift in apparent Ca^2+^ affinity with PCMBS. Plot of normalized 〈I〉 current against the corresponding Ca^2+^~i~ for KCa3.1 and KCa3.1+PCMBS. The symbols represent the experimental data (KCa3.1, ◆, and KCa3.1+PCMBS, ■), which is plotted against the predicted apparent Ca^2+^ affinity (KCa3.1, solid line) and (KCa3.1+PCMBS, dashed line). Model prediction: KCa3.1, EC~50~ = 540 nM, and KCa3.1+PCMBS, EC~50~ = 280 nM. Experimental observation: KCa3.1, EC~50~ = 508 nM, and KCa3.1+PCMBS, EC~50~ = 235 nM.](JGP_201010430_RGB_Fig10){#fig10}

We went on to further validate our kinetic scheme by predicting the apparent Ca^2+^ affinity and the shift in apparent Ca^2+^ affinity mediated by PCMBS. [Fig. 10 C](#fig10){ref-type="fig"} illustrates the simulated Ca^2+^ concentration response curves in the absence (solid line) and presence (dashed line) of PCMBS plotted against the corresponding experimental data. The model accurately predicts the apparent Ca^2+^ affinity as well as the shift induced by PCMBS. The success of the model is not entirely unexpected, since it was initially fit to the kinetic data, which encompasses the steady-state response. Nonetheless, the consistency between the model and the experimental data are reassuring.

PCMBS slows the k~53~ transition
--------------------------------

Previous studies on K^+^ channels have shown that mutations along S6 perturb a concerted transition that occurs late in the activation pathway before opening ([@bib38]). Because our data suggest that PCMBS binds to a S6 residue (Cys^276^), we determined whether the PCMBS-induced perturbation could also be traced to a late opening transition. To answer this, we analyzed activation and deactivation kinetics in the presence of 500 µM PCMBS, in terms of the scheme discussed above, and compared the rate constants with those obtained in the absence of the compound. [Fig. 11](#fig11){ref-type="fig"} A (dashed line) shows the fit of the model to a representative Ca^2+^ jump experiment performed in the presence of PCMBS. As summarized in [Table II](#tbl2){ref-type="table"}, initial modeling showed that PCMBS has complex effects on channel kinetics by altering multiple transitions along the activation and deactivation pathway. The largest changes occur for the k~32~ (15-fold faster), k~35~ (8-fold faster), and k~53~ (7-fold slower) transitions, which made it difficult to interpret our results. However, due to the large parameter space in the kinetic model, it is impossible to prove that the fitted parameters are indeed the best fit. Additionally, it is impossible to know if there are different parameter sets with quantitatively similar goodness of fits. In an effort to account for this uncertainty, we started from the parameter values determined in the absence of PCMBS (k~-PCMBS~), and we only allowed a few parameters to be fit at a time while holding all other values constant. In doing this, we isolated one parameter that is critical for describing the kinetic changes to the channel upon the application of PCMBS, k~53~, the transition rate from the first open state back to the third closed state ([Table II](#tbl2){ref-type="table"}). Simply modifying k~53~ alone (solid line) results in a goodness of fit that is nearly identical to our first attempt (dashed line) indicating that an approximately sevenfold slowing of transition k~53~ can account for our experimental observations (see [Fig. 10 A](#fig10){ref-type="fig"} and [Table II](#tbl2){ref-type="table"}). After extensive parameter searches, we believe these results provide the most parsimonious description of how PCMBS affects the channel; however, more complex interactions involving multiple rates cannot be ruled out. Our results demonstrate that PCMBS slows the first transition along the deactivation pathway, rather than altering a concerted transition late in the activation pathway.

![PCMBS slows transition k~53~, as determined through the constrained version of the model. (A) Representative activation and deactivation records fit with two variations of the model. The dashed line represents the variation that allowed parameters k~12~, k~21~, k~23~, k~32~, k~35~, and k~53~ to be free, and the solid line represents the variation that held parameters k~12~, k~21~, k~23~, k~32~, and k~35~ to k~(-PCMBS)~ values; k~53~ is the only free parameter, see Results for details. As noted in the previous figure, the Ca^2+^-dependent rate constants were assumed to have a nonlinear dependence on Ca^2+^ concentration, k = A · \[Ca\]/(B + \[Ca\]). The colors refer to the different Ca^2+^ concentrations, with red representing 0.5, blue 0.7, green 1.0, and black 10 μM Ca^2+^. (B) Gating scheme detailing that parameter k~53~ is modulated by PCMBS, as determined through the constrained version of the model.](JGP_201010430_RGB_Fig11){#fig11}

L281W replicates the PCMBS phenotype
------------------------------------

Our results suggest that Cys^276^ is located within a gating-sensitive region of the channel, as disrupting this site with PCMBS shifts the gating equilibrium toward the open state. As PCMBS converts cysteine into a mercuriphenyl-sulphonate conjugate ([@bib35]), we attempted to mimic the influence of PCMBS by placing a bulky tryptophan residue at position 276. However, as illustrated in [Fig. 12 A](#fig12){ref-type="fig"}, the C276W mutation had no effect on apparent Ca^2+^ affinity, EC~50~ = 558 ± 50 nM and h = 1.8 ± 0.1 (*n* = 7), when compared with the WT channel EC~50~ = 508 ± 13 nM and h = 2.0 ± 0.1 (*n* = 57). This result demonstrates that Trp^276^ does not reproduce the shift in apparent Ca^2+^ affinity associated with the PCMBS-dependent channel potentiation. It should be noted that PCMBS is negatively charged at pH 7.2. However, experiments to determine whether PCMBS electrostatically disrupts channel structure could not be conducted because we were unable to record macroscopic current from the C276D mutation.

![Trp^281^ and Trp^282^ recapitulate the PCMBS-mediated shift in apparent Ca^2+^ affinity. Complete Ca^2+^ concentration response experiments were performed to estimate EC~50~ and Hill coefficients (h) for those constructs expressing macroscopic currents, as described in [Fig. 3](#fig3){ref-type="fig"}. (A) Plot of normalized 〈I〉 current against the corresponding Ca^2+^~i~ for KCa3.1 C276W (•) and C277W (□). KCa3.1 (▴) and KCa3.1+PCMBS (▵) are included for comparison. KCa3.1 C276W (*n* = 7), EC~50~ = 558 ± 50 nM and h = 1.8 ± 0.1; KCa3.1 C277W (*n* = 6), EC~50~ = 748 ± 54 nM and h = 1.5 ± 0.1; KCa3.1 (*n* = 57), EC~50~ = 508 ± 13 nM and h = 2.0 ± 0.2; and KCa3.1+PCMBS (*n* = 6), EC~50~ = 235 ± 17 nM and h = 2.5 ± 0.2. (B) Plot of normalized 〈I〉 current against the corresponding \[Ca^2+^\]~i~ for KCa3.1 L281W (■), KCa3.1 L281W+PCMBS (□), and KCa3.1 V282W (○). KCa3.1 (▴) and KCa3.1+PCMBS (▵) are included for comparison. KCa3.1 L281W (*n* = 12), EC~50~ = 54 ± 6.4 nM and h = 3.3 ± 0.2; KCa3.1 L281W+PCMBS (*n* = 3), EC~50~ = 43 ± 1.2 nM and h = 3.6 ± 0.5; KCa3.1 V282W (*n* = 12), EC~50~ = 296 ± 14 nM and h = 1.6 ± 0.1; KCa3.1 (*n* = 57), EC~50~ = 508 ± 13 nM and h = 2.0 ± 0.2; and KCa3.1+PCMBS (*n* = 6), EC~50~ = 235 ± 17 nM and h = 2.5 ± 0.2. Error bars represent standard SEM. Error bars smaller than the symbols are not visible in the graph.](JGP_201010430_LW_Fig12){#fig12}

Whereas Trp^276^ does not manipulate apparent Ca^2+^ affinity, PCMBS is a larger molecule, and it may exert its influence at a position distant from the Cys^276^ anchoring point. To examine this possibility, we performed a partial tryptophan scan of S6, from Gly^274^ to Val^282^, and assessed whether these mutations recapitulated any characteristics of the PCMBS phenotype. Mutations G274W, V275W, T278W, A279W, and L280W all failed to produce macroscopic currents, thus preventing their assessment. As shown in [Fig. 12 (A and B)](#fig12){ref-type="fig"} C277W causes a right shift in apparent Ca^2+^ affinity, whereas both L281W and V282W produced left shifts similar to PCMBS. Remarkably, Trp^281^ mediates a large shift in apparent Ca^2+^ affinity, an ∼10-fold increase over the WT (−PCMBS) channel and an ∼4-fold increase over the WT (+PCMBS) channel. To determine whether Trp^281^ and Trp^282^ also recapitulate the changes in kinetic behavior, Ca^2+^ jump experiments were performed. As shown in [Fig. 13](#fig13){ref-type="fig"}, the Trp^281^ mutation mimics the deactivation process, resulting in an approximately threefold slowing relative to the WT channel. However, the mutation had no effect on the activation process. Furthermore, Trp^282^ had no effect on channel activation or deactivation ([Fig. 13, E and F](#fig13){ref-type="fig"}). Since Trp^281^ mimics the PCMBS phenotype, we wanted to assess whether the mutation prevented further modulation with PCMBS. PCMBS did not alter the apparent Ca^2+^ affinity ([Fig. 12 B](#fig12){ref-type="fig"}) or activation kinetics of the Trp^281^ mutation ([Fig. 13, E and F](#fig13){ref-type="fig"}). However, the addition of PCMBS to the mutant channel further slowed channel deactivation by roughly 40% over the four Ca^2+^~i~ concentrations examined ([Fig. 13, E and F](#fig13){ref-type="fig"}), suggesting this compound can still bind Cys^276^, but does not potentiate channel behavior.

![Trp^281^ recapitulates the PCMBS-mediated modulation in deactivation kinetics. Activation and deactivation kinetics were estimated with Ca^2+^ jump experiments as described in [Fig. 4](#fig4){ref-type="fig"} using Ca^2+^~i~ concentrations (A) 0.5, (B) 0.7, (C) 1.0, and (D) 10 µM for L281W (blue trace) and KCa3.1 in the absence (black trace) and presence (red trace) of PCMBS, included for comparison. Activation (E) and deactivation (F) rates were estimated by fitting activation and deactivation records with an exponential function and reported as a time constant (τ-on and τ-off) for KCa3.1 (▴), KCa3.1 PCMBS (▵), L281W (•), L281W PCMBS (○), and V282W (□), see also [Table I](#tbl1){ref-type="table"}.](JGP_201010430_RGB_Fig13){#fig13}

We also assessed whether the four-state model can accurately describe L281W activation and deactivation records from the Ca^2+^ jump experiments. As illustrated in [Fig. 14 A](#fig14){ref-type="fig"}, the four-state model accurately describes the four sets of activation and deactivation time courses. [Fig. 14 B](#fig14){ref-type="fig"} provides an enhanced depiction of the fit outlined by the dashed box in [Fig. 14 A](#fig14){ref-type="fig"}. The rate constants derived from the fit are presented in [Table II](#tbl2){ref-type="table"}. As shown in the table, the values for k~12~, k~21~, and k~53~ are very similar to those values obtained from the initial analysis of KCa3.1+PCMBS. This surprising result suggests that L281W has many kinetic characteristics in common with the PCMBS-modulated channel. Therefore, we asked whether the phenotype displayed by this construct could be explained by only modifying transition k~53~. As shown in [Table II](#tbl2){ref-type="table"}, the parameters from the KCa3.1 model (k~KCa3.1-PCMBS~) were adequate to describe L281W activation and deactivation time courses. This result indicates that slowing of the deactivation process can be explained by slowing of transition k~53~ for both the PCMBS-modulated channel and the L281W construct. As discussed with PCMBS, we cannot rule out that the phenotype present in L281W is the result of complex interactions involving multiple rates. However, it is interesting that parameters from the KCa3.1 data can reproduce the fits for both PCMBS and the L281W Ca^2+^ jump experiments. In total, these results indicate that sterically disrupting Cys^276^ is not adequate to recapitulate the PCMBS phenotype. The results from the tryptophan scan suggest that Leu^281^and Val^282^ are located within a mechanically sensitive region of the channel. More importantly, L281W disrupts steady-state and kinetic behavior in a manner that is similar to PCMBS, suggesting that L281W and PCMBS may disrupt gating through a common mechanism.

![A four-state model can be used to fit the activation and deactivation kinetics for KCa3.1 L281W. (A) Representative activation and deactivation records fit with the model shown in [Fig. 10 A](#fig10){ref-type="fig"}. Activation and deactivation currents were recorded and fit according to the protocol described in the Materials and methods sections. The colors refer to the different Ca^2+^ concentrations, with red representing 0.5, blue 0.7, green 1.0, and black 10 µM Ca^2+^. The dashed line represents the fit assuming Ca^2+^-dependent rate constants have a nonlinear dependence on Ca^2+^ concentration, k = A · \[Ca\]/(B + \[Ca\]). Rate constants derived from the fit are summarized in [Table II](#tbl2){ref-type="table"}. (B) Enhanced depiction of the fit outlined by the box in A.](JGP_201010430_RGB_Fig14){#fig14}

DISCUSSION
==========

Ligand-gated ion channels undergo a series of conformational changes in response to ligand binding, enabling the pore to transition from a nonconducting to a conducting configuration ([@bib13]). A chemo-mechanical gating model has been proposed to explain the Ca^2+^-dependent gating mechanism of K~Ca~ channels ([@bib30], [@bib31]). This model states that the binding of Ca^2+^~i~ to CaM initiates a cascade of conformational changes within CaM/CaMBD. These conformational changes are then coupled, via the S6 transmembrane helix, to the pore, enabling the channel to gate ([@bib37]; [@bib19]; [@bib30], [@bib31]). Here we showed that PCMBS potentiates channel activation by manipulating steady-state and kinetic behavior through modification of Cys^276^. A tryptophan scan of S6 revealed that L281W mimics modification by PCMBS, suggesting that both may act through a common mechanism. Perturbations at each of these sites disrupt channel closing, supporting the notion that the nonluminal surface of this portion of S6 is allosterically coupled to the activation gate. Therefore, the Ca^2+^-dependent activation mechanism utilizes the nonluminal surface along S6 to transition into the closed conformation.

Difference in chemistries of the compounds may explain discrepancy regarding the effect on the WT channel
---------------------------------------------------------------------------------------------------------

It is interesting that MTSET fails to modulate WT channel gating ([@bib33]; [@bib20]), despite our results showing that PCMBS can modulate gating. There are several possible explanations for this difference, but the simplest is related to the chemical difference between PCMBS and MTSET. This conclusion is consistent with previous investigations showing that PCMBS, with a peripherally located cysteine reactive moiety, could access cysteines not accessible to MTSET's more centrally located moiety ([@bib39]; [@bib35]; [@bib26]). Additionally, the larger size of PCMBS conjugated to cysteine was more likely to irreversibly modify behavior rather than transiently affect behavior as observed using MTSET ([@bib39]; [@bib35]; [@bib26]). Thus, the unique chemistry of PCMBS enables this compound to potentiate the WT channel by modifying Cys^276^.

As Cys^276^ is located within a region of the channel (V275-V282) inhibited by MTSET, why does PCMBS not inhibit the channel? The discrepancy in modulation can be explained by the orientation of Cys^276^ relative to the lumen of the pore. Val^275^ is known to line the pore from studies localizing the binding site of clotrimazole and arachidonic acid ([@bib36]; [@bib12]). Results from a substituted cysteine accessibility method analysis confirmed the orientation of this residue, and indicated a similar orientation for Thr^278^ and Val^282^ ([@bib33]). These results are in agreement with sequence alignments ([Table S1](http://www.jgp.org/cgi/content/full/jgp.201010430/DC1)) that indicate Val^275^, Thr^278^, and Val^282^ correspond to residues that are known to line the pore in KcsA ([@bib5]; [@bib11]) and Shaker ([@bib24]). The luminal location of Val^275^, Thr^278^, and Val^282^ indirectly argues for Cys^276^ and Leu^281^ to be oriented away from the pore. Thus, the nonluminal orientation of Cys^276^ prevents PCMBS from modification-induced channel block.

PCMBS potentiates channel activation by shifting the gating equilibrium toward the open conformation
----------------------------------------------------------------------------------------------------

PCMBS cannot activate the channel in the absence of Ca^2+^~i~, ([Fig. 1 D](#fig1){ref-type="fig"}) suggesting the compound potentiates activation, rather than directly opening the gate. Cys^276^ is only accessible in the open conformation ([Fig. 1 D](#fig1){ref-type="fig"}), suggesting that the closed conformation either blocks PCMBS from accessing Cys^276^, or the orientation of Cys^276^ may be inaccessible. A previous investigation indicated that once in the closed state, a constriction develops at the level of Thr^278^-Ala^282^ ([@bib20]). It is possible that this constriction blocks PCMBS from gaining access to Cys^276^.

PCMBS influences both steady-state and kinetic behavior of the channel. The changes to the steady-state behavior occur in subsaturating Ca^2+^~i~ as well as saturating Ca^2+^~i~ concentrations. These changes could occur independently through two separate pathways: a Ca^2+^-dependent pathway that shifts the apparent Ca^2+^ affinity and Ca^2+^-independent pathway that increases P~o(max)~. Thus, the shift in apparent affinity can be explained by either a change in the initial binding of Ca^2+^ to CaM or modification of a conformational change subsequent to Ca^2+^ binding. However, we observed that PCMBS increases P~o(max)~, suggesting that modulation along the Ca^2+^-dependent pathway cannot simply be explained by stabilizing the Ca^2+^/CaM interaction. Rather, it suggests that PCMBS functions to shift the gating equilibrium toward the open conformation. Shifting the gating equilibrium toward the open conformation would explain both the increase in P~o(max)~ and, through a mass action effect, the shift in apparent affinity. Therefore, the changes in steady-state behavior cannot occur through two independent pathways, but are related and a consequence of shifting the equilibrium toward the open conformation. These results are similar to a previous investigation, which characterized potentiation by Ni^2+^ on cyclic nucleotide-activated channels from rod photoreceptors ([@bib10]).

We know from the change in steady-state behavior that PCMBS alters the energy difference between the closed and open conformations to favor channel opening. What we cannot infer from these experiments is whether the energetics of activation, deactivation, or a combination of the two is altered. Based on channel kinetics, PCMBS slows both channel activation and deactivation ([Table I](#tbl1){ref-type="table"}). Although the slowing of channel activation is not congruent with our steady-state data, slowing of channel deactivation is the predominant effect and corresponds well with our steady-state results. Therefore, the primary manner in which PCMBS shifts the gating equilibrium toward the open conformation is by disrupting the energetics of channel deactivation.

We demonstrated that a four-state gating scheme describes the activation and deactivation records of KCa3.1. However, the rates describing the Ca^2+^-dependent transitions must have a nonlinear rather than a linear dependence to fit the activation record in saturating Ca^2+^~i~. This need for nonlinear coefficients is not an artifact of the experimental system, as we were able to describe the full range of kinetic behavior for the closely related channel KCa2.3 (unpublished data). The discrepancy may be related to channel behavior in saturating Ca^2+^~i~, as elevated Ca^2+^~i~ has been reported to block the channel ([@bib22]).

As illustrated in [Table II](#tbl2){ref-type="table"}, k~23~ is substantially higher than the other rate constants, particularly k~12~. As the analysis from Hirschberg et al. reported k~12~ ≈ k~23~ we tested the model where k~12~ = k~23~ to ensure that our results were not biased by k~23~. However, forcing k~12~ = k~23~ results in the model predicting faster activation time courses compared with the rates observed experimentally (unpublished data). Therefore, this analysis suggests k~23~ must be higher than the other rates constants to accurately describe the activation time courses from the four sets of Ca^2+^ concentrations. The discrepancy may exist because we simultaneously fit activation and deactivation records from four sets of Ca^2+^ concentrations, whereas the other investigation fit a single concentration.

Modeling the Ca^2+^-dependent gating of KCa3.1
----------------------------------------------

The results from the initial kinetic analysis showed that good fits to the data can be obtained by modulating all transition rates in the presence of PCMBS. However, more careful reanalysis revealed that only one rate constant, k~53~, had to be changed to explain the influence of PCMBS ([Table II](#tbl2){ref-type="table"}). Reducing k~53~ approximately sevenfold gives excellent fits to the activation and deactivation records, and further substantiates that PCMBS shifts the gating equilibrium toward the open conformation by disrupting channel closing. Assuming k~53~ is the only transition affected by PCMBS may be an over simplification. As depicted in [Table II](#tbl2){ref-type="table"}, PCMBS affects both channel activation and deactivation. Therefore, to address this question we reanalyzed the data, allowing transitions k~12~, k~23~, and k~53~ to change. Our subsequent analysis showed a slowing of the rate constants k~12~ and k~23~, which correlates well with the observed slowing of channel activation ([Table II](#tbl2){ref-type="table"}). However, there was no improvement in the fit when compared with the k~53~ model ([Table II](#tbl2){ref-type="table"}). Therefore, the modest effect of PCMBS on channel activation does not require a substantial change in k~12~ or k~23~. The predominant effect on kinetic behavior is completely accounted for by the change in transition k~53~, which accurately describes the slowing in channel deactivation.

In contrast to the WT channel, the L281W mutation affects channel deactivation without affecting channel activation. Therefore, this made for an ideal model to confirm whether the change in the deactivation process can be completely explained by the change in transition k~53~. The initial kinetic analysis showed that the change in channel deactivation can be explained by an approximately fourfold slowing of transition k~53~, which corresponds well with the observed change in τ-off ([Table I](#tbl1){ref-type="table"}). As predicted, we were able to reproduce the fit from the initial kinetic analysis by modifying only transition k~53~ ([Table II](#tbl2){ref-type="table"}). This result argues that the slowing of channel deactivation observed with PCMBS and L281W can be explained by slowing of transition k~53~. The results from the kinetic analysis correspond well with the observed phenotype for both the PCMBS-modulated channel and the L281W mutation. This correspondence would suggest that PCMBS and the L281W mutation disrupt channel behavior through a common mechanism, which will be discussed further in the following section. Although our data are consistent with PCMBS and L281W stabilizing the open conformation, based upon our analysis of macroscopic currents, we cannot eliminate the possibility that the observed effects are the result of destabilizing the closed conformation ([@bib38]). Therefore, a physical interpretation of the manipulation by PCMBS and L281W is that both perturbations disrupt channel closing, suggesting that Cys^276^ and Leu^281^ are located in a region of S6 that is allosterically coupled to the activation gate.

Potential mechanism of PCMBS
----------------------------

Our results are consistent with PCMBS binding to Cys^276^; however, we cannot recreate this effect by sterically perturbing position 276 with a tryptophan substitution. Furthermore, mutation to Gly^276^, Phe^276^, Tyr^276^, and the aforementioned Ala^276^ and Asp^276^ (no expression) also failed to alter the apparent Ca^2+^ affinity (unpublished data). Although many scenarios may account for this result, the simplest explanation is that Cys^276^ is not coupled to the activation gate. Furthermore, mutation of the adjacent amino acid, C277W, had only modest effects on apparent Ca^2+^ affinity, also suggesting that Cys^277^ is not coupled to the activation gate. These results are in agreement with a previous investigation, which predicted that the channel cavity extends from Val^272^ to Thr^278^ ([@bib33]; [@bib20]). Modeling of the open (computer-derived structure) and closed state using the KcsA structure, indicates that the major conformational change occurs along S6 between Thr^278^ and Val^282^ ([@bib33]). Gating-sensitive residues are found in regions of the channel where amino acid packing rearranges as the channel transitions from one conformational state to another ([@bib38]). Therefore, interpreting our results in the context of previous investigations suggest that mutations at Cys^276^ and Cys^277^ do not modulate gating because this region is predicted to undergo little movement, whereas Leu^281^ and Val^282^ are thought to modulate gating because these positions are predicted to undergo major conformational change ([@bib33]).

Mutating Leu^281^ or Val^282^ to tryptophan shifts the gating equilibrium toward the open state, demonstrating that this region rearranges as the channel transitions between conformational states. More importantly, the Trp^281^ mutation has the additional effect of slowing the deactivation process. The similarity between modification by PCMBS and L281W supports the notion that these two perturbations are disrupting the channel through a common mechanism. Thus, PCMBS and L281W may function to shift the gating equilibrium toward the open conformation by either stabilizing the open state or destabilizing the closed state ([@bib38]). Our data cannot eliminate either of these possibilities. Therefore, we propose two hypotheses to describe how PCMBS and the L281W mutation disrupt the gating of KCa3.1. To attempt to visualize rearrangements that occur in this region during gating, we constructed a closed-state model of KCa3.1 based on the KcsA x-ray structure and an open-state model based on Kv1.2 ([Fig. 15](#fig15){ref-type="fig"}). The open state model predicts that Leu^281^ is oriented toward S5 ([Fig. 15](#fig15){ref-type="fig"}, inset). Our kinetic modeling predicts that PCMBS and L281W slow transition k~53~. Therefore, our first hypothesis is that these perturbations hinder the possible rotational movement of S6 that was shown to accompany the closed to open transition in the KcsA K^+^ channel ([@bib27]). The increase in side-chain volume with the L281W mutation could sterically hinder the rotation of S6 by disrupting a potential S5/S6 interaction. Additionally, [@bib1] characterized the binding mechanism of PCMBS to Charcot-Leyden crystal protein and determined that PCMBS binds to Cys^57^ but results in downstream perturbation at the Arg^60^ side chain. Therefore, PCMBS may interact with neighboring residues in the open state to disrupt the conformational change in S6. This model supports our data well because these interactions could energetically stabilize the open conformation. However, we cannot rule out the possibility that PCMBS and L281W shift the gating equilibrium toward the open conformation by destabilizing the closed conformation of the channel. Along these lines, the open- and closed-state models of KCa3.1 predict that Cys^276^ and Leu^281^ sterically clash in the closed state but not in the open state. Therefore, an alternate hypothesis is that when PCMBS is conjugated to Cys^276^, it disrupts the closing transition by sterically clashing with Leu^281^. The L281W mutation would work through a similar mechanism, except this mutation would disrupt the closing transition by sterically clashing with Cys^276^. Although there is an agreement between the length of PCMBS and the distance between the β carbons of the corresponding residues from KcsA and KirBac1.1 ([Fig. 15](#fig15){ref-type="fig"}), the steric clash predicted by this model could lead to an energetic destabilization of the closed state. This conclusion is inconsistent with our kinetic modeling. Furthermore, the KcsA structure cannot account for the closed conformation of KCa3.1, as the region in KCa3.1, corresponding to the bundle crossing in KcsA, does not function as an activation gate ([@bib20]; [@bib9]). Thus, while this is an interesting model that predicts an intersubunit interaction, it is an unlikely representation for the molecular function of PCMBS.

![Homology model of the pore region for the open and closed state of KCa3.1. (Left) Representation of the S5-P-helix-S6 region viewed as a profile illustrating the predicted orientation of Cys^276^ (yellow) and the L281W mutation (red) in the closed state using the KcsA structure. (Inset) Structure of PCMBS adapted from the crystal structure of PCMBS in complex with the Charcot-Leyden crystal protein ([@bib1]). PCMBS is 6.5 Å in length and 9.0 Å in length when the thiol group is included. The color red represents oxygen molecules, yellow (sulfur), cyan (carbon), and white (mercury). (Right) Representation of the S5-P-helix-S6 region viewed as a profile illustrating the predicted orientation of Cys^276^ (yellow) and the L281W mutation (red) in the open state based upon the structure of rKv1.2. Sequence alignments used for homology modeling can be found in [Fig. 5 C](#fig5){ref-type="fig"}. (Inset) Representation of S5 and S6 viewed from the intercellular aspect of the pore to illustrate that Leu^281^ (L281W) is oriented toward S5. Cys^276^ and L281W from the adjacent subunit are the only residues illustrated to compare the predicted orientation in the closed and open state. The S5 and P-helix are colored green and the S6 helix is colored blue. All residues are illustrated in VDW format. The C-terminal portion of the S5 helix was removed to prevent obscuring the view of L281W.](JGP_201010430_RGB_Fig15){#fig15}

Activation mechanism: implications from PCMBS modulation and the L281W mutation
-------------------------------------------------------------------------------

Ligand-gated ion channels are composed of a pore-domain, a ligand-binding domain, and a coupling mechanism, which links the ligand binding sites within the ligand-binding domain to the activation gate in the pore domain ([@bib16]). Although, various hypotheses exist to explain the coupling mechanism, the interacting surfaces between transmembrane domains have been proposed as a coupling mechanism for activation of Kv channels ([@bib15]; [@bib21]). Movement of one transmembrane domain can influence the conformation of an adjacent transmembrane domain through side-chain contact points radiating from adjacent helices. We presented arguments for both Cys^276^ and Leu^281^ adopting a nonluminal orientation, and disrupting these sites alters the steady-state and kinetic behavior of the channel. Our results correspond well with previous investigations, which proposed that the activation gate for this family of ion channels is located at or near the selectivity filter ([@bib3]; [@bib4]; [@bib20]), suggesting that the region between the gate and CaMBD must be incorporated into the coupling mechanism. Therefore, our results would suggest that the nonluminal face of S6, specifically the C-terminal region, is allosterically coupled to the activation gate. This idea corresponds well with prior investigations that isolated a gating-sensitive region (Ala^283^, Val^285^, and Ala^286^) in the C-terminal portion of S6 ([@bib33]; [@bib20]), in addition to a position (Val^282^) required for transitioning into the closed conformation ([@bib9]). However, unlike the previous investigations, which proposed a mechanism for pore-lining residues participating in the activation mechanism, we provide evidence that the nonluminal face of S6 also actively participates in the activation mechanism, functioning as a key interaction surface required for transitioning into the closed state.
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